Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials

Detalles Bibliográficos
Autores principales: Longshaw, Christopher, Roger, Echols, Santerre Henriksen, Anne, Baba, Takamichi, Nguyen, Sean, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578404/
https://www.ncbi.nlm.nih.gov/pubmed/36094308
http://dx.doi.org/10.1128/aac.01100-22
_version_ 1784811961517604864
author Longshaw, Christopher
Roger, Echols
Santerre Henriksen, Anne
Baba, Takamichi
Nguyen, Sean
Yamano, Yoshinori
author_facet Longshaw, Christopher
Roger, Echols
Santerre Henriksen, Anne
Baba, Takamichi
Nguyen, Sean
Yamano, Yoshinori
author_sort Longshaw, Christopher
collection PubMed
description
format Online
Article
Text
id pubmed-9578404
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-95784042022-10-19 Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials Longshaw, Christopher Roger, Echols Santerre Henriksen, Anne Baba, Takamichi Nguyen, Sean Yamano, Yoshinori Antimicrob Agents Chemother Letter to the Editor American Society for Microbiology 2022-09-12 /pmc/articles/PMC9578404/ /pubmed/36094308 http://dx.doi.org/10.1128/aac.01100-22 Text en Copyright © 2022 Longshaw et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Longshaw, Christopher
Roger, Echols
Santerre Henriksen, Anne
Baba, Takamichi
Nguyen, Sean
Yamano, Yoshinori
Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials
title Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials
title_full Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials
title_fullStr Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials
title_full_unstemmed Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials
title_short Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials
title_sort evidence for efficacy of cefiderocol against oxa-48-containing isolates from the apeks-np and credible-cr trials
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578404/
https://www.ncbi.nlm.nih.gov/pubmed/36094308
http://dx.doi.org/10.1128/aac.01100-22
work_keys_str_mv AT longshawchristopher evidenceforefficacyofcefiderocolagainstoxa48containingisolatesfromtheapeksnpandcrediblecrtrials
AT rogerechols evidenceforefficacyofcefiderocolagainstoxa48containingisolatesfromtheapeksnpandcrediblecrtrials
AT santerrehenriksenanne evidenceforefficacyofcefiderocolagainstoxa48containingisolatesfromtheapeksnpandcrediblecrtrials
AT babatakamichi evidenceforefficacyofcefiderocolagainstoxa48containingisolatesfromtheapeksnpandcrediblecrtrials
AT nguyensean evidenceforefficacyofcefiderocolagainstoxa48containingisolatesfromtheapeksnpandcrediblecrtrials
AT yamanoyoshinori evidenceforefficacyofcefiderocolagainstoxa48containingisolatesfromtheapeksnpandcrediblecrtrials

Ejemplares similares